Ermanno Puxeddu Selected Research

Ermanno Puxeddu Research Topics

Disease

19	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 01/2013
8	Asthma (Bronchial Asthma) 02/2022 - 01/2016
4	Dyspnea (Shortness of Breath) 10/2021 - 12/2013
4	Idiopathic Pulmonary Fibrosis 03/2019 - 06/2014
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 12/2013
2	Pneumonia (Pneumonitis) 02/2022 - 04/2021
2	Hypoxia (Hypoxemia) 10/2021 - 12/2013
2	Inflammation (Inflammations) 10/2019 - 01/2018
2	Chronic Disease (Chronic Diseases) 10/2019 - 01/2017
2	Disease Progression 01/2018 - 10/2009
2	Pulmonary Hypertension 01/2018 - 06/2014
1	Post-Acute COVID-19 Syndrome 02/2023
1	Invasive Fungal Infections 01/2019
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018
1	Hypersensitivity (Allergy) 05/2017
1	Hemochromatosis (Bronze Diabetes) 02/2015
1	Fibrosis (Cirrhosis) 02/2015
1	Hemorrhage 06/2014

Drug/Important Bio-Agent (IBA)

7	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 02/2016
3	Muscarinic AntagonistsIBA 11/2021 - 01/2017
3	Formoterol Fumarate (Oxis)FDA Link 04/2021 - 10/2015
3	IronIBA 01/2018 - 06/2014
2	Oxygen (Dioxygen)IBA 10/2021 - 12/2013
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2021 - 01/2016
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2021 - 01/2018
2	Expectorants (Mucolytics)IBA 05/2019 - 01/2018
2	AntioxidantsIBA 05/2019 - 01/2018
2	AntigensIBA 01/2019 - 10/2009
2	Bronchodilator Agents (Bronchodilators)IBA 01/2018 - 04/2016
1	Drug CombinationsIBA 02/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2022
1	vilanterolIBA 04/2021
1	GSK573719IBA 04/2021
1	Beclomethasone (Beclometasone)FDA Link 04/2021
1	fluticasone furoate FDA Link 04/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	velsecoratIBA 01/2020
1	GW870086XIBA 01/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	2,2,2- trifluoro- N- (1- ((1- (4- fluorophenyl)- 1H- indazol- 5- yl)oxy)- 1- (3- methoxyphenyl)- 2- propanyl)acetamideIBA 01/2020
1	Receptor for Advanced Glycation End ProductsIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	erdosteineIBA 05/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 05/2019
1	Carbocysteine (S-Carboxymethylcysteine)IBA 05/2019
1	pirfenidoneIBA 03/2019
1	galactomannanIBA 01/2019
1	GoldIBA 01/2018
1	ciclesonide FDA Link 01/2018
1	RoflumilastIBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	CytokinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Vasopressins (Vasopressin)IBA 05/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 05/2017
1	LatexIBA 05/2017
1	tiotropium-olodaterolIBA 04/2016
1	Tiotropium Bromide (Spiriva)FDA Link 04/2016
1	olodaterolIBA 04/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	Coloring Agents (Dyes)IBA 02/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015
1	Malondialdehyde (Propanedial)IBA 02/2015
1	SmokeIBA 06/2014
1	indacaterolIBA 01/2013

Therapy/Procedure

13	Therapeutics 02/2023 - 01/2013
3	Nebulizers and Vaporizers (Inhaler) 11/2019 - 01/2016
2	Precision Medicine 01/2018 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2024
1	Biological Therapy 01/2018
1	Obstetric Surgical Procedures 05/2017
1	Polypharmacy 01/2017
1	Duration of Therapy 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Dry Powder Inhalers 01/2016
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2016